Comparison of serum and placental levels of an enzyme (angiotensin-converting enzyme)and a vasodilator (nitric oxide) in preeclampsia patients
Not Applicable
- Conditions
- Health Condition 1: O149- Unspecified pre-eclampsia
- Registration Number
- CTRI/2019/01/016890
- Lead Sponsor
- Kasturba Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Cases: Patients diagnosed with preeclampsia who are in their 3rd trimester of pregnancy
Controls: Healthy subjects in the 3rd trimester of pregnancy who do not exhibit symptoms of preeclampsia and gestational diabetes.
Exclusion Criteria
Pregnant subjects showing complications such as gestational diabetes, hypertension, etc are excluded.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Difference in levels of serum and placental angiotensin-converting enzyme (ACE) and nitric oxide (NO) between case and control groupsTimepoint: Samples are collected in 3rd trimester of pregnancy
- Secondary Outcome Measures
Name Time Method Correlation between serum ACE and NO <br/ ><br>Correlation between placental ACE and NOTimepoint: Samples are collected in 3rd trimester of pregnancy